Anaptysbio (ANAB) Capital Expenditures (2016 - 2026)
Anaptysbio's Capital Expenditures was $17,000 in Q1 2026, down 51.4% from $35,000 a year earlier.
Powered by 
Analysis
Anaptysbio (ANAB) Capital Expenditures (2016 - 2026) Analysis & Trends
On a trailing twelve-month basis, Anaptysbio's Capital Expenditures was $69,000 through Mar 31, 2026, down 81.1% year-over-year; for FY2025, it came in at $87,000, down 75.7% from FY2024.
- Capital Expenditures shows a five-year compound annual growth rate of -31.3% (FY2020 to FY2025).
- In earlier years, Capital Expenditures was $358,000 in FY2024 (-55.6%), $807,000 in FY2023 (+125.4%), $358,000 in FY2022 (-73.8%) and $1.37 million in FY2021 (+140.1%).
- Quarterly Capital Expenditures has moved between $1,000 (Q4 2025) and $863,000 (Q2 2021) over five years.
- Compared with a year earlier, Capital Expenditures has declined for three straight quarters, with an average decline of 42.0% over the last eight quarters.
- The best year-over-year quarter for Capital Expenditures over five years was Q2 2021 (growth of 939.8%); the worst was Q4 2025 (a decline of 99.6%).
- Per Business Quant data, ANAB's Capital Expenditures in the three quarters before Q1 2026 was $1,000 (Q4 2025), $12,000 (Q3 2025) and $39,000 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Anaptysbio | 1.46 Bn | 346.34 Mn | - | 17,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 17,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 12,000.00 |
| Jun 30, 2025 | 39,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Dec 31, 2024 | 263,000.00 |
| Sep 30, 2024 | 35,000.00 |
| Jun 30, 2024 | 33,000.00 |
| Mar 31, 2024 | 27,000.00 |
| Dec 31, 2023 | 280,000.00 |
| Sep 30, 2023 | 162,000.00 |
| Jun 30, 2023 | 190,000.00 |
| Mar 31, 2023 | 175,000.00 |
| Dec 31, 2022 | 175,000.00 |
| Sep 30, 2022 | 50,000.00 |
| Jun 30, 2022 | 78,000.00 |
| Mar 31, 2022 | 55,000.00 |
| Dec 31, 2021 | 14,000.00 |
| Sep 30, 2021 | 172,000.00 |
| Jun 30, 2021 | 863,000.00 |
API Access
Anaptysbio Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ANAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ANAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ANAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();